Oxajulolidinyl‐Induced Molecular Twisting in Aza‐BODIPY Nanoplatform for NIR‐Triggered Synergistic Phototherapy of Glioblastoma
Small · 09.11.2026
DOI: 10.1002/smll.76702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 09.11.2026. Verfasst von Pingting Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute For Strategic Materials and Components, Shenyang University of Chemical Technology, Shenyang, China. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liaoning & Shenyang Key Laboratory of Functional Dye and Pigment.
Abstract (Originalsprache)
Glioblastoma (GBM) remains a formidable challenge in oncology due to its infiltrative nature and the blood‐brain barrier that impedes drug delivery. Herein, we report three novel oxajulolidinyl ( OJLD )‐functionalized aza‐BODIPY photosensitizers ( Ph‐OJLD , OMe‐OJLD , and CF 3 ‐OJLD ) designed for NIR‐triggered synergistic photodynamic and photothermal therapy. The OJLD moiety induces significant molecular distortion, as confirmed by single‐crystal X‐ray diffraction, which promotes reactive oxygen species generation and photothermal conversion. Ph‐OJLD self‐assembles into uniformly dispersed nanoplatforms (233 nm, polydispersity index = 0.11) with a negative surface charge (−46.1 mV). In vitro, laser‐activated Ph‐OJLD nanoparticles (NPs) suppress U251 cell proliferation and migration, induce mitochondrial damage, and trigger apoptosis. In an orthotopic GL261 glioma model, stereotactic injection of Ph‐OJLD NPs followed by NIR laser irradiation significantly reduces tumor size and enhances apoptosis without observable toxicity. This work establishes oxajulolidinyl modification as a promising strategy for designing multifunctional photosensitizers for GBM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute For Strategic Materials and Components, Shenyang University of Chemical Technology, Shenyang, China.
- Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
- Science Experiment Center, China Medical University, Shenyang, China.
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, China.
- College of Materials Science and Engineering, Shenzhen University, Shenzhen, China.
ORCID-Profile: Yingnan Wu, Dongping Xu, Xiaoqiang Chen, Xin-Dong Jiang, Xiaohong Sun, Xiaojun Peng
Förderung
- National Natural Science Foundation of China
- Liaoning & Shenyang Key Laboratory of Functional Dye and Pigment
Zitieren
APA
Wang, P., Hai, S., Gao, X., Xue, Y., Wu, Y., Xu, D., Chen, X., Jiang, X. D., Sun, X., Peng, X., & Qin, G. (2026). Oxajulolidinyl‐Induced Molecular Twisting in Aza‐BODIPY Nanoplatform for NIR‐Triggered Synergistic Phototherapy of Glioblastoma. Small. https://doi.org/10.1002/smll.76702
Vancouver
Wang P, Hai S, Gao X, Xue Y, Wu Y, Xu D, et al. Oxajulolidinyl‐Induced Molecular Twisting in Aza‐BODIPY Nanoplatform for NIR‐Triggered Synergistic Phototherapy of Glioblastoma. Small. 2026. doi:10.1002/smll.76702
BibTeX
@article{Wang2026,
author = {Wang, Pingting and Hai, Shuangshuang and Gao, Xiaoyan and Xue, Yunsheng and Wu, Yingnan and Xu, Dongping and Chen, Xiaoqiang and Jiang, Xin-Dong and Sun, Xiaohong and Peng, Xiaojun and Qin, Gaowu},
title = {Oxajulolidinyl‐Induced Molecular Twisting in Aza‐BODIPY Nanoplatform for NIR‐Triggered Synergistic Phototherapy of Glioblastoma},
journal = {Small},
year = {2026},
doi = {10.1002/smll.76702}
}
EUVIMED